Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Ron Pedersen"'
Autor:
Walter P. Maksymowych, Pascal Claudepierre, Manouk de Hooge, Robert G. Lambert, Robert Landewé, Anna Molto, Désirée van der Heijde, Jack F. Bukowski, Heather Jones, Ron Pedersen, Annette Szumski, Bonnie Vlahos, Maxime Dougados
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-14 (2021)
Abstract Background Limited information is available on the impact of treatment with a tumor necrosis factor inhibitor (TNFi) on structural lesions in patients with recent-onset axial spondyloarthritis (axSpA). We compared 2-year structural lesion ch
Externí odkaz:
https://doaj.org/article/907b9f77ff8d48f985da26d6f8f858f6
Autor:
Maxime Dougados, Désirée van der Heijde, Wen-Chan Tsai, Diego Saaibi, Lisa Marshall, Heather Jones, Ron Pedersen, Bonnie Vlahos, Miriam Tarallo
Publikováno v:
Health and Quality of Life Outcomes, Vol 18, Iss 1, Pp 1-7 (2020)
Abstract Background We assessed the external validity of composite indices Ankylosing Spondylitis Disease Activity Score (ASDAS), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and Assessment in SpondyloArthritis international Society (
Externí odkaz:
https://doaj.org/article/2d1362b014d141ba8b0920f7afe31b00
Autor:
Pavol Polák, Porin Peric, Ingrid Louw, Stefanie M. Gaylord, Theresa Williams, Jean-Claude Becker, Ron Pedersen, Joan Korth-Bradley, Bonnie Vlahos
Publikováno v:
European Journal of Rheumatology, Vol 6, Iss 1, Pp 23-28 (2019)
Externí odkaz:
https://doaj.org/article/76b1c75f567f43c2ae727eea527d45a8
Autor:
Robert J Moots, Ricardo M Xavier, Chi Chiu Mok, Mahboob U Rahman, Wen-Chan Tsai, Mustafa H Al-Maini, Karel Pavelka, Ehab Mahgoub, Sameer Kotak, Joan Korth-Bradley, Ron Pedersen, Linda Mele, Qi Shen, Bonnie Vlahos
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0179308 (2017)
[This corrects the article DOI: 10.1371/journal.pone.0175207.].
Externí odkaz:
https://doaj.org/article/ae31931fea8a46669c33dfddcbc80e96
Autor:
Robert J Moots, Ricardo M Xavier, Chi Chiu Mok, Mahboob U Rahman, Wen-Chan Tsai, Mustafa H Al-Maini, Karel Pavelka, Ehab Mahgoub, Sameer Kotak, Joan Korth-Bradley, Ron Pedersen, Linda Mele, Qi Shen, Bonnie Vlahos
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0175207 (2017)
OBJECTIVE:To assess the incidence of anti-drug antibodies (ADA) in patients with rheumatoid arthritis (RA) treated with the TNF inhibitors etanercept (ETN), adalimumab (ADL), or infliximab (IFX), and determine the potential relationship with trough d
Externí odkaz:
https://doaj.org/article/6af16e2d555b4839b6545a44c5ff9ea2
Autor:
Christopher J Edwards, Sara M. Burns, Joan Sopczynski, Heather Jones, Ron Pedersen, Lisa Marshall, Jack F. Bukowski
Publikováno v:
Drugs & Aging. 37:35-41
The aim of this study was to use real-world data to evaluate potential interactions between age, treatment, and the risk of developing four adverse events (AEs) common in the elderly: congestive heart failure, serious infections, non-melanoma skin ca
Autor:
Bonnie Vlahos, Pavol Polák, Ingrid Louw, Ron Pedersen, Joan M. Korth-Bradley, Jean‐Claude Becker, Stefanie Gaylord, Theresa Williams, Porin Perić
Publikováno v:
European Journal of Rheumatology, Vol 6, Iss 1, Pp 23-28 (2019)
European Journal of Rheumatology
European Journal of Rheumatology
Objective: To evaluate the immunogenicity, safety, and efficacy of etanercept (ETN) manufactured using the serum-free, high-capacity manufacturing (SFHCM) process in patients with rheumatoid arthritis (RA). ----- Methods: In this global, multicenter,
Autor:
Heather Jones, Annette Szumski, Robert Landewé, Maxime Dougados, Anna Molto, Bonnie Vlahos, Walter P. Maksymowych, Pascal Claudepierre, Ron Pedersen, Désirée van der Heijde, Robert G. W. Lambert, Jack F. Bukowski, Manouk de Hooge
Publikováno v:
Arthritis research & therapy, 23(1):43. BioMed Central
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-14 (2021)
Arthritis Research & Therapy
Arthritis Research & Therapy, 2021, 23 (1), pp.43. ⟨10.1186/s13075-021-02428-8⟩
ARTHRITIS RESEARCH & THERAPY
Arthritis Research & Therapy, BMC, 2021, 23 (1), pp.43. ⟨10.1186/s13075-021-02428-8⟩
Arthritis Research and Therapy, 23(1). BMC
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-14 (2021)
Arthritis Research & Therapy
Arthritis Research & Therapy, 2021, 23 (1), pp.43. ⟨10.1186/s13075-021-02428-8⟩
ARTHRITIS RESEARCH & THERAPY
Arthritis Research & Therapy, BMC, 2021, 23 (1), pp.43. ⟨10.1186/s13075-021-02428-8⟩
Arthritis Research and Therapy, 23(1). BMC
Background Limited information is available on the impact of treatment with a tumor necrosis factor inhibitor (TNFi) on structural lesions in patients with recent-onset axial spondyloarthritis (axSpA). We compared 2-year structural lesion changes on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c6450aaf89d4f2a545ebd23a1941fe1
https://hdl.handle.net/1887/3196080
https://hdl.handle.net/1887/3196080
Publikováno v:
Modern rheumatology. 31(2)
To compare the radiographic and clinical effects of 25 versus 10 mg twice-weekly (BIW) etanercept over 52 weeks in Japanese patients with active rheumatoid arthritis (RA).This was aAt week 52, there were no significant differences between 25 and 10 m
Autor:
Ron Pedersen, Maxime Dougados, Désirée van der Heijde, Lisa Marshall, Wen-Chan Tsai, M. Tarallo, Bonnie Vlahos, Diego Luis Saaibi, Heather Jones
Publikováno v:
Health and Quality of Life Outcomes
Health and Quality of Life Outcomes, Vol 18, Iss 1, Pp 1-7 (2020)
Health and Quality of Life Outcomes, 18(1). BMC
Health and Quality of Life Outcomes, Vol 18, Iss 1, Pp 1-7 (2020)
Health and Quality of Life Outcomes, 18(1). BMC
Background We assessed the external validity of composite indices Ankylosing Spondylitis Disease Activity Score (ASDAS), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and Assessment in SpondyloArthritis international Society (ASAS) 40
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::413ff5372ea7066b13a3aa17f7d20ef8
https://hdl.handle.net/1887/3182994
https://hdl.handle.net/1887/3182994